School of Medicine


Showing 1,751-1,800 of 2,422 Results

  • Risheen Reejhsinghani

    Risheen Reejhsinghani

    Clinical Associate Professor, Medicine - Cardiovascular Medicine

    BioRisheen Reejhsinghani obtained her medical degree in Mumbai, India, followed by an internal medicine residency at St. Elizabeth's Medical Center in Boston, MA and cardiology fellowship at Baystate Medical Center/Tufts University School of Medicine, where she served as one of the chief fellows. She subsequently completed an advanced echocardiography fellowship at the University of California, San Francisco, and is board certified in echocardiography, general cardiology, and nuclear cardiology.

    Dr. Reejhsinghani practices as a general cardiologist in the Division of Cardiovascular Medicine at Stanford University School of Medicine, where she also serves as the associate director for the hospital-based consultative cardiology service. As a clinical cardiologist, she believes strongly in the tenets of evidence-based practice, diagnostic cognizance, and patient education. She also has a specific interest in the burgeoning field of Cardio-Rheumatology, focused on cardiac diseases among patients with rheumatologic conditions such as rheumatoid arthritis, systemic lupus erythematosus, scleroderma, and ankylosing spondylitis, among others. Her clinical research in this area has focused on the evaluation of structural cardiac disease and diastolic dysfunction in ankylosing spondylitis patients, primarily using echocardiography.

    Dr. Reejhsinghani has an academic focus in medical education, and believes that instilling a love for bedside medicine and the physical exam is the soundest way to empower future generations of learners. To this end, she received additional training in clinical teaching and simulation at the University of California, San Francisco, and has worked extensively on curriculum and course design. She currently serves as the associate program director of the cardiovascular medicine fellowship at Stanford, and is an associate course director for the Year 1 Practice of Medicine Course at the Stanford University medical school. Dr. Reejhsinghani also enjoys writing, particularly about medical education and has written articles for international newspapers, among other publications.

  • David Rehkopf

    David Rehkopf

    Director, Stanford Center on Longevity, Professor of Epidemiology and Population Health, of Sociology, of Medicine (Primary Care and Population Health) and, by courtesy, of Pediatrics, and of Health Policy

    BioI am a social epidemiologist and Professor in the Department of Epidemiology and Population Health, the Department of Sociology, and the Division of Primary Care and Population Health in the Department of Medicine. I joined the Stanford University faculty in 2011.

    My research examines the health implications of the myriad decisions made every day by corporations and governments—decisions that profoundly shape the social and economic worlds in which we live and work. Although these changes are often invisible in daily life, seemingly minor actions and decisions can serve as structural nudges that produce better or worse health at the population level. My work documents the health consequences of corporate and governmental decisions, providing evidence that can help the public and policymakers develop new strategies to promote health and well-being. Across this work, I focus particularly on the implications of these exposures for health inequalities.

    Because policy and programmatic changes can take decades to influence health, my research also includes more basic work to identify biological signals that may serve as early warning signs of systemic disease, particularly accelerated aging. I examine how social and economic policy changes affect a range of early markers of disease and aging, with a recent focus on DNA methylation. I am supported by several grants from the National Institute on Aging and the National Institute on Minority Health and Health Disparities to develop more sensitive approaches for understanding the health effects of social and economic policy changes.

  • David A. Relman

    David A. Relman

    Thomas C. and Joan M. Merigan Professor and Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsMy investigative program focuses on human-microbe interactions and human microbial ecology, and primarily concerns the ecology of human indigenous microbial communities; a secondary interest concerns the classification of humans with systemic infectious diseases, based on features of genome-wide gene transcript abundance patterns and pther aspects of the host response.

  • Cybele A. Renault, MD, DTM&H, FIDSA

    Cybele A. Renault, MD, DTM&H, FIDSA

    Clinical Professor, Medicine - Infectious Diseases

    BioDr. Renault has devoted her career to caring for vulnerable patient populations, both domestically and overseas. She completed her medical school and residency training at the University of Chicago, caring for underserved patients on Chicago's South Side, followed by a Chief Resident year at John H. Stroger, Jr. Hospital of Cook County, the public hospital serving the uninsured in Chicago. She began her career in global health as an Infectious Diseases fellow at Stanford, validating low-cost HIV diagnostics in Burkina Faso, and providing clinical service and teaching in India and Zimbabwe as a fellow, and later in Thailand, Uganda, Rwanda, Kenya and Ethiopia as one of our Infectious Diseases faculty. Her clinical work is focused on caring for our Veteran population, working to empower Veterans to engage in their care, often in the setting of significant mental illness.

    Dr. Renault is most passionate about medical education and program development to combat global antimicrobial resistance through antimicrobial stewardship, to create opportunities for the Internal Medicine residents centering on caring for vulnerable patient populations, and to develop impactful and sustainable programs in collaboration with our low- and middle-income partners for our Center for Innovation in Global Health. She served as Associate Program Director for the Internal Medicine Residency Program for 4 years prior to transitioning to her current role as Program Lead for Global Health, for which she leads the Global Health Track for the Internal Medicine residency program and develops global health initiatives for the Department of Medicine. She co-founded and has been director of the Stanford 2-week intensive global health course since its inception in 2012, she has structured trainee and faculty rotations based on evolving needs of our partner sites in Uganda, Rwanda, Zimbabwe, and Sri Lanka, and she is leading Stanford's Internal Medicine virtual case-based education initiative to support our newest medical school partner in Negele Arsi, Ethiopia.

    Dr. Renault strives to augment Stanford's contributions and support for underserved patient populations in the United States. She established resident rotations in Shiprock, New Mexico and Chinle, Arizona through the Indian Health Service, and she is Faculty Advisor for the Internal Medicine Health Equity, Advocacy and Research concentration in the residency program. She also aspires to improve resources for women physicians. In 2016, Dr. Renault established the GME Women in Medicine Leadership Council, with the intention of creating community and encouraging conversations about professional and personal life decisions as women in the field of medicine. She is passionate about mentoring through sharing personal experiences, creating an environment that encourages reflection, and building skills to address challenges unique to women in medicine.

    In 2022, in recognition of her passion for medical education and her success in program development, Dr. Renault was asked to join the leadership at Palo Alto Veterans Health Care System as Deputy Designated Education Officer in the Office of Education. In this role, she works with rotation directors to optimize their respective rotations to offer robust educational opportunities for trainees across specialties who are rotating at the Palo Alto VA.

  • Kavita Renduchintala

    Kavita Renduchintala

    Clinical Assistant Professor, Medicine

    BioKavita Renduchintala, MD is a Clinical Assistant Professor in the Division of Hospital Medicine at Stanford University School of Medicine. She earned her medical degree from the Keck School of Medicine of the University of Southern California (USC) and completed her residency training in Internal Medicine at LAC + USC Medicine Center in Los Angeles.

    Dr. Renduchintala’s clinical background includes caring for hospitalized patients across a range of internal medicine settings. Before joining Stanford, she worked at the University of Chicago, where she provided both general medicine and oncologic hospitalist care. She has also held roles in oncologic hospitalist medicine at Moffitt Cancer Center and in surgical co-management at Keck Hospital of USC.

    Her academic interests focus on medical education, with a particular focus on transitions that occur during medical training. She is dedicated to supporting trainees and enhancing the learning environment in academic hospital medicine. Her research has also explored vaccine uptake among cancer survivors.

  • Chloe Reuter

    Chloe Reuter

    Clinical Associate Professor, Medicine - Cardiovascular Medicine
    Clinical Associate Professor, Pediatrics - Medical Genetics

    BioChloe Reuter is a Genetic Counselor and Clinical Associate Professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine. She is Principal Investigator of an NIH-funded research program focused on developing frameworks for the clinical translation of multi-omic technologies in rare diseases.

    Ms. Reuter provides genetic counseling care at the Stanford Center for Inherited Cardiovascular Diseases, specializing in inherited cardiovascular conditions including cardiomyopathies, arrhythmia syndromes, and sudden cardiac death. She has expertise in interpreting complex genomic results from multi-gene panels, exome sequencing, and whole genome sequencing for patients with rare and undiagnosed diseases.

    Ms. Reuter's research centers on translating cutting-edge genomic technologies into clinical practice. She develops frameworks for integrating multi-omic data (genomic, transcriptomic, and other omics) into diagnostic workflows and contributes to evidence-based guidelines for variant interpretation and clinical curation. Her work addresses the ethical and practical challenges of implementing these technologies, with particular focus on patient engagement, equitable access to precision medicine, and protocols for returning complex research results. She also conducts genetic counseling practice research, examining patient experiences, psychosocial assessment tools, and healthcare delivery models including telehealth services.

    She has contributed to multiple national genomics initiatives including the Undiagnosed Diseases Network and the GREGoR Consortium, applying comprehensive genomic approaches to solve medical mysteries and improve diagnostic outcomes for patients with rare diseases.

  • Andrew Rezvani, M.D.

    Andrew Rezvani, M.D.

    Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    Current Research and Scholarly InterestsClinical research in allogeneic hematopoietic cell transplantation

  • Fauzia Riaz, MD, MHS

    Fauzia Riaz, MD, MHS

    Assistant Professor of Medicine (Oncology)

    BioDr. Riaz is advancing biomarker-driven precision medicine in breast cancer through innovative clinical trials that integrate cutting-edge therapeutics and molecular insights.

    Her research focuses on circulating tumor DNA (ctDNA) to detect minimal residual disease (MRD) in early-stage breast cancer, aiming to guide personalized treatment strategies. She is also developing novel approaches to enhance immunotherapy efficacy by modulating the tumor microenvironment, including early-phase trials that combine immunotherapy with radiotherapy. As an Assistant Professor at Stanford University School of Medicine, Dr. Riaz is committed to ensuring that these next-generation therapies are accessible to all patients..

  • Tia Rich, PhD

    Tia Rich, PhD

    Director, Contemplation by Design, Med/SPRC - Division

    Current Role at StanfordLecturer, School of Medicine, Community Health and Prevention Research
    Director, Stanford Contemplation by Design

  • Stephen Richmond

    Stephen Richmond

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Stephen Richmond is a family physician and educator with specific interest in community health and service-learning experiences. He currently serves as a clinical assistant professor of medicine in the Division of Primary Care & Population Health (PCPH) in the Stanford Department of Medicine. He completed his A.S. at Solano Community College, B.A. in Molecular & Cell Biology at UC Berkeley, M.P.H. at Harvard T.H. Chan School of Public Health, and his M.D. at David Geffen School of Medicine, UCLA. He is a graduate of the UCSF-San Francisco General Hospital Family & Community Medicine Residency Program. As a clinician, Dr. Richmond cares for individuals of all ages with a wide range of acute and chronic illnesses. Beyond the clinic, he is especially passionate about teaching medical students and strengthening community partnerships.

  • Sonia Rios-Ventura

    Sonia Rios-Ventura

    Family Health Navigator, Medicine - Med/Oncology

    BioSonia Rios-Ventura is a clinical research coordinator associate for the Stanford School of Medicine, department of Cancer Genetics and Genomics. She received her B.A. in anthropology and intensive sociology from the University of California Santa Cruz.

    She is also the family health navigator for the Genetic Information and Family Testing (GIFT) Study. GIFT's mission is to help families beat cancer. It aims to save lives through education and communication about cancer risk and prevention in families. When someone learns they have a genetic mutation that increases their risk for cancer, it means their family members might also be at risk. For too long, the difficult job of talking about family cancer risk has fallen to the cancer patients alone. GIFT is here to make it easier for people to share this important information and give family members an easy way to get genetic testing to learn about their personal cancer risk. GIFT is an online program developed by cancer patients, family members, and doctors that offers a new way to, 1. Share life-saving information about family cancer risk and ways to lower that risk, 2.Connect interested family members to easy, at-home genetic testing.

  • Edwin Omar Rivera-López

    Edwin Omar Rivera-López

    Postdoctoral Scholar, Infectious Diseases

    BioEdwin Omar Rivera-López is a Postdoctoral Scholar in the Bollyky Lab at Stanford University. He earned his dual-title Ph.D. in Food Science and Clinical and Translational Sciences from The Pennsylvania State University under the mentorship of Dr. Edward G. Dudley, where he studied bacteriophage–host interactions in Escherichia coli O157 using functional genomics to identify the genetic determinants of phage adsorption and host defense. His current research focuses on developing phage–antibiotic therapies for the treatment of polymicrobial bacterial infections associated with cystic fibrosis.

  • Norman Rizk

    Norman Rizk

    Berthold and Belle N. Guggenhime Professor, Emeritus

    Current Research and Scholarly InterestsI am interested in the prevention and control of critical care-related illnesses and complications, including ventilator-associated pneumonia, spread of nosocomial infections, and prognosis of multiple organ system failure in intensive care units. Infections and complications of therapy in immunocompromised hosts, including effects of chemotherapy and hematopoetic stem cell transplants is another interest.

  • Farhana Rob, DO

    Farhana Rob, DO

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Farhana Rob is a board-certified, fellowship-trained family medicine doctor with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Primary Care and Population Health at Stanford University School of Medicine.

    Dr. Rob provides personalized and compassionate primary care for people ranging from newborns to older adults. She specializes in women’s health and maternity care, managing conditions such as heavy menstrual bleeding, pregnancy-induced hypertension, and gestational diabetes. She also has expertise in birth control, discussing and providing options particularly for adolescents and postpartum mothers. Dr. Rob also specializes in minor injuries and musculoskeletal problems, providing therapies such as laceration repair, tendon and joint injections, and trigger point injections.

    Dr. Rob emphasizes preventive care and early diagnosis through routine and diagnostic screenings. She strives to empower them to become active participants in their health care. She is open to discussing alternative and natural treatments to support holistic healing. Dr. Rob also enjoys teaching and has mentored medical students and residents throughout her career.

    Dr. Rob has published research on heart failure in peer-reviewed journals including the Journal of Cardiovascular Electrophysiology. She shared her findings on using ultrasound to estimate birthweight at the American Academy of Family Physicians Family-Centered Pregnancy Care Conference. She has also written about heavy menstrual bleeding for The 5-Minute Clinical Consult, a physician guidebook that focuses on evidence-based medicine.

    Dr. Rob is a member of the American Academy of Family Physicians, the American Board of Family Medicine, and the American Medical Association.

  • Jennifer Robinson

    Jennifer Robinson

    Associate Director, Medicine - Med/Stanford Prevention Research Center

    Current Role at StanfordAssociate Director, Nutrition Studies Group

  • Thomas Robinson

    Thomas Robinson

    The Irving Schulman, M.D. Professor of Child Health, Professor of Medicine (Stanford Prevention Research Center) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Robinson originated the solution-oriented research paradigm and directs the Stanford Solutions Science Lab. He is known for his pioneering obesity prevention and treatment research, including the concept of stealth interventions. His research applies social cognitive models of behavior change to behavioral, social, environmental and policy interventions for children and families in real world settings, making the results relevant for informing clinical and public health practice and policy.

  • William H. Robinson, MD PhD

    William H. Robinson, MD PhD

    James W. Raitt, M.D. Professor

    Current Research and Scholarly InterestsOur overarching objective is to elucidate the molecular and cellular mechanisms underlying autoimmune and rheumatic diseases and translate these discoveries into next-generation diagnostics and therapeutics.

  • Nancy Robles, NP-C

    Nancy Robles, NP-C

    Affiliate, Medicine - Med/Cardiovascular Medicine

    BioI'm an advanced practice provider with a focus in inherited cardiovascular disease, neuromuscular disease associated cardiomyopathies, advanced heart failure, and sports cardiology. I also have a strong background in Emergency Medicine and trauma. Hablo Espanol.

  • Stanley G. Rockson, MD

    Stanley G. Rockson, MD

    Allan and Tina Neill Professor of Lymphatic Research and Medicine

    Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.

  • Desirée Rodrigues Plaça

    Desirée Rodrigues Plaça

    Postdoctoral Scholar, Infectious Diseases

    Current Research and Scholarly InterestsI am studying Flaviviridae viruses, focusing on dengue. My research explores T cell and myeloid dysregulation in severe dengue to improve vaccines and identify biomarkers. I'm characterizing T cell responses to DENV, and the regulatory immune response through integrative systems analysis. My ultimate goal is to contribute to the development of improved diagnostic tools and vaccines for pediatric infectious diseases, particularly in endemic regions like Brazil.

  • Fatima Rodriguez

    Fatima Rodriguez

    Robert and Shirley Raymer Professor

    BioFatima Rodriguez, MD, MPH serves as the Vice Chair of Clinical Research (Department of Medicine), Section Chief of Preventive Cardiology, and Associate Director of the Center for Digital Health at Stanford University. She received her medical degree from Harvard Medical School and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Dr. Rodriguez completed her internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford.

    Dr. Rodriguez specializes in the prevention and management of cardiovascular disease, with clinical expertise in coronary artery disease and inherited lipid disorders. Her research focuses on cardiovascular disease prevention and health promotion, leveraging digital tools to improve guideline-based care, and using AI-enabled approaches for early detection of atherosclerosis.

  • Albert "A.J." Rogers, MD, MBA, FAHA, FHRS

    Albert "A.J." Rogers, MD, MBA, FAHA, FHRS

    Assistant Professor of Medicine (Cardiovascular Medicine)

    BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is Assistant Professor of Medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.

    As a clinical cardiac electrophysiologist, Dr. Rogers’ expertise includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). This includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.

    Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.

    As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 15 years of experience with medical technology innovation and development.

    Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society.

  • Angela Rogers

    Angela Rogers

    Professor-Univ Med Line, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.

  • Nidhi Rohatgi, MD MS

    Nidhi Rohatgi, MD MS

    Clinical Professor, Medicine
    Clinical Professor (By courtesy), Neurosurgery
    Clinical Professor (By courtesy), Anesthesiology, Perioperative and Pain Medicine

    BioNidhi Rohatgi, MD, MS, SFHM, is a Clinical Professor of Medicine and (by courtesy) Neurosurgery and Anesthesiology, Perioperative, and Pain Medicine at Stanford University School of Medicine. She is Affiliate Faculty at Stanford's Center for Artificial Intelligence in Medicine and Imaging (AIMI), Institute for Human-Center AI (HAI), and Center for Digital Health.

    Dr. Rohatgi's work focuses on what makes clinical interventions, and increasingly AI, succeed or fail in real-world care. She has written on LLMs for clinical text summarization and pharmacogenomics, multimodal in-context learning (NeurIPS 2025), the promises and limitations of AI, and digital twins for surgical site infections (IISE/ANNSIM 2026). Her current interests include real-world evaluation and implementation of AI across the care continuum, and identifying where AI can improve outcomes and reduce cost. She collaborates with clinicians, engineers, health systems, and industry partners on translating AI into safe, effective clinical practice. She delivered the keynote on Engineering AI for Real Clinical Impact at the 2026 IEEE International Conference on Sustainability, Innovation, and Technology. In her upcoming book, she shares a blueprint for AI in medicine: where AI can help and how, global health AI trends, and tackling costs.

    Her perspective is grounded in more than a decade of leading and scaling clinical programs at Stanford. For over 10 years, she has led Clinical Advice Services in Patient Experience as Medical Director, developing evidence- and consensus-based clinical decision support for clinical triage across 30+ medical and surgical subspecialties and 200+ clinics (~1 million calls/year). Under her leadership, this award-winning service has built a strong track record in patient safety, reduced unnecessary ED and clinic visits, and reduced pages to on-call teams by over 90%. She also served as Chief of Surgical Co-management for Neurosurgery, ENT, and Orthopedic Surgery, Co-Director of Clinical Research in Hospital Medicine, and Physician Lead of Stanford Health Care's Readmissions Committee.

    Dr. Rohatgi has authored peer-reviewed articles in high-impact journals (NEJM, Lancet, JAMA, Nature, Annals of Surgery) and book chapters in Perioperative Medicine, and has served as principal investigator and co-investigator for NIH and industry-sponsored trials. She is Editor-in-Chief of JMIR Perioperative Medicine and serves on the Editorial Board of Brown University's Journal of Hospital Medicine. A global advisor on surgical co-management models, she chaired the Society of Hospital Medicine's Global Technical Advisory Committee on co-management and has served on multiple national committees in research, quality and patient safety, perioperative medicine, and practice management. Recognized as a Top Hospitalist by the American College of Physicians, she has received numerous national and international awards for clinical care, quality improvement, teaching, and research, and has been an invited faculty and keynote speaker at regional, national, and international meetings.

    Her unique lens spans clinical experience managing patients in medical and surgical specialties, research on millions of patient records, clinical trials, patient experience, clinical triage, and health system operations. Dr. Rohatgi is passionate about innovative, value-based, sustainable solutions and exploring new frontiers in healthcare.

  • Rajat Rohatgi

    Rajat Rohatgi

    Professor of Biochemistry and of Medicine (Oncology)

    Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.

  • Benjamin Rolles

    Benjamin Rolles

    Postdoctoral Scholar, Hematology

    BioMD/Research Fellow
    @MullallyLab @StanfordMed @VAPaloAlto @BrighamHeme @BrighamResearch @HarvardMed

    Studied
    @UniklinikAachen @RWTH

    Interested in MPN & Myeloid Malignancies